Skip to content

Retention of pre-ART patients poor in sub-Saharan Africa

Herpes drugs and viral load: valaciclovir works better than aciclovir

Valaciclovir slows HIV disease progression in pregnant and breastfeeding women

New integrase inhibitor dolutegravir looks potent and well-tolerated

Another NRTI-sparing regimen does well in treatment-naive patients

New NNRTI lersivirine matches efavirenz in phase 2 study

Spanish steps

Juanse Hernández and Xavier Franquet of Grupo de Trabajo sobre Tratamientos del VIH (gTt), Barcelona. Image by Caspar Thomson (aidsmap.com)

Once-daily elvitegravir matches raltegravir

HIV treatment in primary infection: 48 week course modestly delays CD4 drop